Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Progress and prospects of early detection in lung cancer.

Blandin Knight S, Crosbie PA, Balata H, Chudziak J, Hussell T, Dive C.

Open Biol. 2017 Sep;7(9). pii: 170070. doi: 10.1098/rsob.170070. Review.

2.

BARD1 serum autoantibodies for the detection of lung cancer.

Pilyugin M, Descloux P, André PA, Laszlo V, Dome B, Hegedus B, Sardy S, Janes S, Bianco A, Laurent GJ, Irminger-Finger I.

PLoS One. 2017 Aug 7;12(8):e0182356. doi: 10.1371/journal.pone.0182356. eCollection 2017.

3.

Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer.

Dai L, Li J, Tsay JJ, Yie TA, Munger JS, Pass H, Rom WN, Tan EM, Zhang JY.

Oncoimmunology. 2017 Mar 31;6(5):e1310359. doi: 10.1080/2162402X.2017.1310359. eCollection 2017.

PMID:
28638733
4.
5.

Review of carcinogenicity of asbestos and proposal of approval standards of an occupational cancer caused by asbestos in Korea.

Im S, Youn KW, Shin D, Lee MJ, Choi SJ.

Ann Occup Environ Med. 2015 Dec 30;27:34. doi: 10.1186/s40557-015-0080-1. eCollection 2015.

6.

Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals.

Cui JW, Li W, Han FJ, Liu YD.

Transl Lung Cancer Res. 2015 Jun;4(3):275-86. doi: 10.3978/j.issn.2218-6751.2015.02.05. Review.

7.

A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer.

Yu Z, Lu H, Si H, Liu S, Li X, Gao C, Cui L, Li C, Yang X, Yao X.

PLoS One. 2015 May 21;10(5):e0125517. doi: 10.1371/journal.pone.0125517. eCollection 2015.

8.

Screening tests: a review with examples.

Maxim LD, Niebo R, Utell MJ.

Inhal Toxicol. 2014 Nov;26(13):811-28. doi: 10.3109/08958378.2014.955932. Epub 2014 Sep 29. Review.

9.

Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers.

Hulbert A, Hooker CM, Keruly JC, Brown T, Horton K, Fishman E, Rodgers K, Lee B, Sam C, Tsai S, Weihe E, Pridham G, Drummond B, Merlo C, Geronimo M, Porter M, Cox S, Li D, Harline M, Teran M, Wrangle J, Mudge B, Taylor G, Kirk GD, Herman JG, Moore RD, Brown RH, Brock MV.

J Thorac Oncol. 2014 Jun;9(6):752-9. doi: 10.1097/JTO.0000000000000161.

10.

Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CT.

Huellner MW, Collen TD, Gut P, Winterhalder R, Pauli C, Diebold J, Seifert B, Strobel K, Veit-Haibach P.

EJNMMI Res. 2014 Jan 22;4(1):6. doi: 10.1186/2191-219X-4-6.

11.

Lung cancer screening.

Gutierrez A, Suh R, Abtin F, Genshaft S, Brown K.

Semin Intervent Radiol. 2013 Jun;30(2):114-20. doi: 10.1055/s-0033-1342951. Review.

12.

Overdiagnosis in low-dose computed tomography screening for lung cancer.

Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR; NLST Overdiagnosis Manuscript Writing Team.

JAMA Intern Med. 2014 Feb 1;174(2):269-74. doi: 10.1001/jamainternmed.2013.12738. Erratum in: JAMA Intern Med. 2014 May;174(5):828.

13.

Lung cancer screening with low-dose computed tomography.

Chiles C.

Radiol Clin North Am. 2014 Jan;52(1):27-46. doi: 10.1016/j.rcl.2013.08.006.

14.

Lung cancer screening: from imaging to biomarker.

Xiang D, Zhang B, Doll D, Shen K, Kloecker G, Freter C.

Biomark Res. 2013 Jan 16;1(1):4. doi: 10.1186/2050-7771-1-4.

15.

Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions.

Rzyman W, Jelitto-Gorska M, Dziedzic R, Biadacz I, Ksiazek J, Chwirot P, Marjanski T.

Interact Cardiovasc Thorac Surg. 2013 Dec;17(6):969-73. doi: 10.1093/icvts/ivt388. Epub 2013 Sep 5.

16.

Computer-aided diagnosis systems for lung cancer: challenges and methodologies.

El-Baz A, Beache GM, Gimel'farb G, Suzuki K, Okada K, Elnakib A, Soliman A, Abdollahi B.

Int J Biomed Imaging. 2013;2013:942353. doi: 10.1155/2013/942353. Epub 2013 Jan 29.

17.

Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.

Aberle DR, Abtin F, Brown K.

J Clin Oncol. 2013 Mar 10;31(8):1002-8. doi: 10.1200/JCO.2012.43.3110. Epub 2013 Feb 11. Review.

18.

American Cancer Society lung cancer screening guidelines.

Wender R, Fontham ET, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle GS, Kelsey DK, LaMonte SJ, Michaelson JS, Oeffinger KC, Shih YC, Sullivan DC, Travis W, Walter L, Wolf AM, Brawley OW, Smith RA.

CA Cancer J Clin. 2013 Mar-Apr;63(2):107-17. doi: 10.3322/caac.21172. Epub 2013 Jan 11. Review.

19.

CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort.

Greenberg AK, Lu F, Goldberg JD, Eylers E, Tsay JC, Yie TA, Naidich D, McGuinness G, Pass H, Tchou-Wong KM, Addrizzo-Harris D, Chachoua A, Crawford B, Rom WN.

PLoS One. 2012;7(7):e39403. doi: 10.1371/journal.pone.0039403. Epub 2012 Jul 2.

20.

Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers.

Hazelton WD, Goodman G, Rom WN, Tockman M, Thornquist M, Moolgavkar S, Weissfeld JL, Feng Z.

Math Biosci. 2012 Nov;240(1):20-34. doi: 10.1016/j.mbs.2012.05.008. Epub 2012 Jun 15.

Supplemental Content

Support Center